K
Koji Matsuo
Researcher at University of Southern California
Publications - 434
Citations - 7820
Koji Matsuo is an academic researcher from University of Southern California. The author has contributed to research in topics: Medicine & Cervical cancer. The author has an hindex of 35, co-authored 346 publications receiving 5528 citations. Previous affiliations of Koji Matsuo include Baylor College of Medicine & LAC+USC Medical Center.
Papers
More filters
Journal ArticleDOI
Paraneoplastic Thrombocytosis in Ovarian Cancer
Rebecca L. Stone,Alpa M. Nick,Iain A. McNeish,Frances R. Balkwill,Hee Dong Han,Justin Bottsford-Miller,Rajesha Rupaimoole,Guillermo N. Armaiz-Pena,Chad V. Pecot,Jermaine Coward,Michael T. Deavers,Hernan G. Vasquez,Diana L. Urbauer,Charles N. Landen,Wei Hu,Hannah Gershenson,Koji Matsuo,Mian M.K. Shahzad,Erin R. King,Ibrahim Tekedereli,Bulent Ozpolat,Edward H. Ahn,Virginia K. Bond,Rui Wang,Angela F. Drew,Francisca C. Gushiken,Donald M. Lamkin,Katherine Collins,Koen DeGeest,Susan K. Lutgendorf,Wah Chiu,Gabriel Lopez-Berestein,Vahid Afshar-Kharghan,Anil K. Sood +33 more
TL;DR: Findings support the existence of a paracrine circuit wherein increased production of thrombopoietic cytokines in tumor and host tissue leads to paraneoplasticThrombocytosis, which fuels tumor growth.
Journal ArticleDOI
Regulation of Tumor Angiogenesis by EZH2
Chunhua Lu,Hee Dong Han,Lingegowda S. Mangala,Rouba Ali-Fehmi,Christopher S. Newton,Laurent Ozbun,Guillermo N. Armaiz-Pena,Wei Hu,Rebecca L. Stone,Adnan R. Munkarah,Murali Ravoori,Mian M.K. Shahzad,Mian M.K. Shahzad,Jeong Won Lee,Jeong Won Lee,Edna M. Mora,Edna M. Mora,Robert R. Langley,Amy R. Carroll,Koji Matsuo,Whitney A. Spannuth,Rosemarie Schmandt,Nicholas B. Jennings,Blake W. Goodman,Robert B. Jaffe,Alpa M. Nick,Hye Sun Kim,Hye Sun Kim,Eylem Güven,Ya Huey Chen,Long Yuan Li,Long Yuan Li,Ming Chuan Hsu,Robert L. Coleman,George A. Calin,Emir Baki Denkbaş,Jae Yun Lim,Ju Seog Lee,Vikas Kundra,Michael J. Birrer,Mien Chie Hung,Mien Chie Hung,Gabriel Lopez-Berestein,Anil K. Sood +43 more
TL;DR: It is shown that increased Zeste homolog 2 (EZH2) expression in either tumor cells or in tumor vasculature is predictive of poor clinical outcome, and the potential for targeting ezh2 as an important therapeutic approach is supported.
Journal ArticleDOI
Sustained small interfering RNA delivery by mesoporous silicon particles
Takemi Tanaka,Lingegowda S. Mangala,Pablo E. Vivas-Mejia,René Nieves-Alicea,Aman P. Mann,Edna M. Mora,Edna M. Mora,Hee Dong Han,Mian M.K. Shahzad,Mian M.K. Shahzad,Xuewu Liu,Xuewu Liu,Rohan Bhavane,Jianhua Gu,Jean R. Fakhoury,Jean R. Fakhoury,Ciro Chiappini,Chunhua Lu,Koji Matsuo,Biana Godin,Rebecca L. Stone,Alpa M. Nick,Gabriel Lopez-Berestein,Anil K. Sood,Mauro Ferrari +24 more
TL;DR: The first in vivo therapeutic validation of a novel, multistage siRNA delivery system for sustained gene silencing with broad applicability to pathologies beyond ovarian neoplasms is provided.
Journal ArticleDOI
Validation of the 2018 FIGO cervical cancer staging system
TL;DR: The 2018 FIGO staging system for cervical cancer is useful to distinguish survival groups; stage IB1 and stage IB2 disease have distinct characteristics and survival outcomes, while survival in stage IIIC1 varies depending on local tumor factors.
Journal ArticleDOI
Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer
Jack L. Watkins,Premal H. Thaker,Alpa M. Nick,Lois M. Ramondetta,Sanjeev Kumar,Diana L. Urbauer,Koji Matsuo,Kathryn C. Squires,Robert L. Coleman,Susan K. Lutgendorf,Pedro T. Ramirez,Anil K. Sood +11 more
TL;DR: In this article, the authors examined the impact of beta-adrenergic blockade on the clinical outcome of women with epithelial ovarian, primary peritoneal, or fallopian tube cancers.